We are live on
!
Find out more
ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
0 hedge funds and large institutions have $0 invested in Achillion Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 129 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 132 → 0 (-132)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $755M → $0 (-$755M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 129
Holders
–
Holders Change
-132
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
129
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$79M |
| 2 |
BlackRock
New York
|
-$68.8M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$45.8M |
| 4 |
VI
Versor Investments
New York
|
-$45.3M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$45.3M |
